Latest news and press releases about Stereotaxis, Inc. (STXS): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Price
| Price | $1.32 |
| Market Cap | $129M |
| Exchange | AMEX |
| Country | US |
Valuation Ratios
| Price / Book | 7.04 |
| EV / EBITDA | -5.77 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -132.62% |
| Return on Invested Capital | -74.49% |
| Return on Assets | -40.16% |
| Gross Margin | 55.57% |
| Operating Margin | -73.02% |
| Net Margin | -74.24% |
Related companies: ARCT · CVRX · HUMA · MDXH · NEO · OSUR · QTRX
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of STXS: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks